Stay updated on Durvalumab and Tremelimumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Tremelimumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Tremelimumab in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.5) was added on 2026-08-06 with a 'Study Status' note, while the prior revision (v3.6.4) was removed on 2026-05-12.
    Difference
    0.3%
    Check dated 2026-08-08T18:02:15.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision: v3.6.4 has been added to the history, replacing the previous v3.6.3. This reflects a platform/UI update to the record history page rather than any substantive change to the trial data.
    Difference
    0.1%
    Check dated 2026-07-25T08:24:45.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The footer now shows revision v3.6.3, replacing v3.6.2. This reflects a minor update to the record history page interface.
    Difference
    0.1%
    Check dated 2026-07-03T22:08:50.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page’s revision notice updated from v3.6.0 to v3.6.2. This reflects a newer version of the site's interface/backend for the Record History view.
    Difference
    0.1%
    Check dated 2026-06-26T23:44:23.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Added a new revision entry v3.6.0 with a recruitment status note 'No longer looking for participants.' The previous revision entry v3.5.5 was removed.
    Difference
    0.2%
    Check dated 2026-06-12T13:35:14.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.4 to v3.5.5. This indicates a new release of the page rendering rather than any change to the underlying study information.
    Difference
    0.1%
    Check dated 2026-06-05T08:36:53.000Z thumbnail image

Stay in the know with updates to Durvalumab and Tremelimumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Tremelimumab in NSCLC Clinical Trial page.